
PCI-32765 racemate
CAS No. 936563-87-0
PCI-32765 racemate( Ibrutinib Racemate | PCI32765 Racemate | PCI 32765 Racemate )
Catalog No. M16704 CAS No. 936563-87-0
A potent a+M7692nd highly selective Btk inhibitor with IC50 of 0.5 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 235 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePCI-32765 racemate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent a+M7692nd highly selective Btk inhibitor with IC50 of 0.5 nM.
-
DescriptionA potent a+M7692nd highly selective Btk inhibitor with IC50 of 0.5 nM; modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.Blood Cancer Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsIbrutinib Racemate | PCI32765 Racemate | PCI 32765 Racemate
-
PathwayTyrosine Kinase
-
TargetBTK
-
RecptorBTK
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number936563-87-0
-
Formula Weight440.4971
-
Molecular FormulaC25H24N6O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
-
Chemical Name2-Propen-1-one, 1-[3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Honigberg LA, et al. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80.
2. Herman SE, et al. Blood. 2014 May 22;123(21):3286-95.
3. Kohrt HE, et al. Blood. 2014 Mar 20;123(12):1957-60.
molnova catalog



related products
-
PCI-32765 racemate
A potent a+M7692nd highly selective Btk inhibitor with IC50 of 0.5 nM.
-
BLK degrader 1
BLK degrader 1 is a selective B lymphoid tyrosine kinase (BLK) degrader with anticancer activity and can be used for cancer research.
-
Acalabrutinib
A novel, irreversible, covalent second-generation BTK inhibitor with IC50 of 3 nM.